<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(1)</volume><submitter>Zhuang Y</submitter><funding>Fujian Clinical Medical Research Center for Immune Kidney Disease</funding><funding>This study was supported by grants from the Key Clinical Specialty Discipline Construction Program of Fujian</funding><journal>Chronic diseases and translational medicine</journal><pagination>1-11</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10914012</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Advances in the treatment of IgA nephropathy with biological agents</pubmed_title><pmcid>PMC10914012</pmcid><funding_grant_id>2017ZDZKSB</funding_grant_id><funding_grant_id>2021Y2016</funding_grant_id><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Lu H</pubmed_authors><pubmed_authors>Zhuang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Advances in the treatment of IgA nephropathy with biological agents</name><description/><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Dec</publication><modification>2024-11-14T22:19:46.733Z</modification><creation>2024-11-14T22:19:46.733Z</creation></dates><accession>S-EPMC10914012</accession><cross_references/></HashMap>